市场调查报告书
商品编码
1492375
颈动脉支架市场:按类型、材料和最终用户划分 - 2024-2030 年全球预测Carotid Stents Market by Type (Balloon-expandable Stents, Self-expanding Stents), Material (Metallic Stents, Polymer Stents), End-user - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
颈动脉支架市场规模预估2023年为5.8822亿美元,预估2024年将达6.2098亿美元,2030年将达8.7805亿美元,复合年增长率为5.88%。
颈动脉支架是一种由金属网製成的小型管状装置。用于医疗程序以确保颈动脉的通畅。对于因动脉壁内斑块堆积导致狭窄(称为颈动脉疾病)而面临中风风险的人来说,该手术至关重要。包括中风在内的心血管疾病的增加增加了对颈动脉支架的需求。医生和患者越来越倾向于恢復时间较短的微创手术,这推动了颈动脉支架的需求和市场成长。与支架置入术相关的风险和併发症正在阻碍颈动脉支架市场的成长。支架置入术技术的进步,包括更安全、更有效的颈动脉支架材料和设计,预计将为市场成长创造机会。
主要市场统计 | |
---|---|
基准年[2023] | 5.8822 亿美元 |
预测年份 [2024] | 62098万美元 |
预测年份 [2030] | 87805万美元 |
复合年增长率(%) | 5.88% |
区域洞察
由于对中风预防的高度认识和先进的医疗基础设施,美洲对颈动脉支架的需求强劲。该市场也受到与文明病(例如导致心血管疾病的肥胖和糖尿病)的流行所推动。此外,有利的报销政策和正在进行的提高颈动脉支架疗效和安全性的临床试验正在支持该市场的成长。亚太地区颈动脉支架市场正在快速成长。促成这一增长的因素包括医疗基础设施的改善、医疗保健支出的增加以及对心血管健康相关疾病的认识提高。中国和印度等人口众多的国家正开始改善医疗服务的可近性。欧洲因其完善的医疗保健系统和高度的预防医学意识而成为颈动脉支架的领先地区。强大的法律规范和领先医疗保健公司的存在也有助于市场的稳定成长。中东和非洲拥有多样化的医疗保健管道和多样化的市场。富裕的海湾国家正在增加对医疗基础设施的投资,为市场成长提供了潜力。
FPNV定位矩阵
FPNV 定位矩阵对于评估供应商在颈动脉支架市场的定位至关重要。此矩阵提供了对供应商的全面评估,并检查了与商务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果,供应商被分为代表其成功程度的四个像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对颈动脉支架市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献,您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外,该分析也为该领域的竞争性质提供了宝贵的见解,包括累积研究期、片段化优势和合併特征等因素。有了这些详细信息,供应商可以做出更明智的决策并製定有效的策略,以在市场竞争中保持领先地位。
策略分析与建议
策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对颈动脉支架市场目前地位的全面评估使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析,以确定核心优势和需要改进的领域。
[191 Pages Report] The Carotid Stents Market size was estimated at USD 588.22 million in 2023 and expected to reach USD 620.98 million in 2024, at a CAGR 5.88% to reach USD 878.05 million by 2030.
Carotid stents are small, tube-shaped devices made of metal mesh. They are used in a medical procedure to ensure the carotid arteries remain open. This procedure is essential for individuals at risk of stroke due to the narrowing caused by plaque buildup inside the artery walls, a condition known as carotid artery disease. Increasing inccidences of cardiovascular diseases, including heart strokes, are drivng the need for carotid stents. The growing inclination towards minimally invasive surgeries among doctors and patients that involve shorter recovery time is driving the need for carotid stents and driving market growth. Risks and complications associated with stenting procedures hamper the growth of the carotid stents market. Rising improvements in stenting technology, including the materials and design of carotid stents that make them safer and more effective, are expected to create opportunities for market growth.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 588.22 million |
Estimated Year [2024] | USD 620.98 million |
Forecast Year [2030] | USD 878.05 million |
CAGR (%) | 5.88% |
Regional Insights
Americas shows a robust demand for carotid stents due to high awareness of stroke prevention and advanced healthcare infrastructure. The prevalence of lifestyle-related diseases such as obesity and diabetes, which contribute to cardiovascular disorders, also boosts the market. Furthermore, favorable reimbursement policies and ongoing clinical trials to improve the efficacy and safety of carotid stents support growth in this market. The APAC region is experiencing rapid growth in the carotid stents market. Factors contributing to this growth include improving health infrastructure, increasing spending on healthcare, and raising awareness of diseases related to cardiovascular health. Countries including, China and India have large populations beginning to have better access to healthcare services. Europe is a major region for carotid stents due to well-established healthcare systems and high awareness about preventative healthcare. The strong regulatory framework and the presence of leading healthcare companies also contribute to steady market growth. The Middle East and Africa have a diverse market with varying access to healthcare. The wealthier Gulf countries show potential for market growth due to increasing investment in health infrastructure.
Market Insights
The market dynamics represent an ever-changing landscape of the Carotid Stents Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Carotid Stents Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Carotid Stents Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Silk Road Medical Launches Advanced Carotid Stent System in the U.S.
Silk Road Medical, Inc. introduced the Tapered ENROUTE Transcarotid Stent System to U.S. hospitals. This advancement builds on the existing ENROUTE system, featuring new configurations to better align with individual patient anatomies. The system supports the Transcarotid Artery Revascularization (TCAR) procedure, a minimally invasive approach designed to significantly enhance stroke protection while reducing complications. This launch marks a significant step in customized, patient-centered stroke intervention strategies. [Published On: 2024-03-05]
Expanded Medicare Coverage Facilitates Access to Cordis Carotid Stents
Cordis endorsed a new policy by the Centers for Medicare & Medicaid Services (CMS) that extends coverage for minimally invasive carotid artery treatments. This decision enhances patient access to the Precise Pro Rx carotid stent system, developed by Cordis for endovascular carotid therapy. The company commended the medical community for effectively demonstrating the benefits of carotid artery stenting (CAS), underlying its commitment to supporting advancements in cardiovascular health management. [Published On: 2023-10-16]
Breakthrough in Stroke Prevention: Introduction of CGuard Prime by InspireMD
InspireMD, Inc., successfully treated the first patient suffering from carotid artery disease with its innovative CGuard Prime stent. This procedure is part of the company's CGuardians U.S. IDE trial. CGuard Prime represents InspireMD's latest advancement in carotid artery stenting (CAS) technology, showcasing ongoing efforts to enhance stroke prevention strategies. [Published On: 2023-05-01]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Carotid Stents Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Carotid Stents Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, B. Braun SE, Balton Sp. z o. o., Becton, Dickinson and Company, Biotronik SE & Co KG, Boston Scientific Corporation, Cardinal Health, Inc., Contego Medical, Inc., Cook Group Incorporated, InspireMD Inc., Medtronic PLC, MicroPort Scientific Corporation, Silk Road Medical, Inc., Stryker Corporation, W. L. Gore & Associates, Inc., and Zhejiang Barty Medical Technology Co., Ltd..
Market Segmentation & Coverage